3.525
price up icon53.59%   1.23
 
loading

Finanzdaten der Jaguar Health Inc-Aktie (JAGX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
93.96%
1.225
20.27 3.235 3.083 2.979
Cost Of Revenue
10.97%
1.031
1.158 2.20 0.532 0.527
Research and Development
15.07%
3.336
3.928 14.31 - -
Interest Income/Expense
76.97%
0.161
0.699 0.132 0.006 -0.015
Costs And Expenses
12.57%
8.822
10.09 24.48 10.32 10.99
Operating Income/Loss
174.61%
-7.597
10.18 -21.24 -7.238 -8.007
Income/Loss From Equity Method Investments
200.00%
-0.027
-0.009 -0.042 -0.045 -0.042
Income/Loss From Continuing Operations Before Tax
246.76%
-12.80
8.723 -23.19 -9.648 -10.56
Income Tax Expense/Benefit
-
- - - -
Net Income/Loss
246.76%
-12.80
8.723 -23.19 -9.648 -10.56
Preferred Stock Dividends And Other Adjustments
99.69%
0.019
6.063 - - -
Attributable To Noncontrolling Interest
4.76%
-0.12
-0.126 -0.132 -0.146 -0.153
Basic Average Shares
56.87%
0.8091
0.5158 - 1.5132 1.0148
Diluted Average Shares
56.87%
0.8091
0.5158 - 1.5132 1.0148
Basic Earnings Per Share
15.44%
-15.70
-13.60 - -6.28 -10.26
Diluted Earnings Per Share
15.44%
-15.70
-13.60 - -6.28 -10.26
$6.58
price down icon 4.22%
$9.94
price down icon 3.21%
$5.53
price down icon 3.66%
$11.27
price down icon 6.16%
$18.60
price down icon 1.74%
WVE WVE
$3.13
price down icon 1.88%
Kapitalisierung:     |  Volumen (24h):